Cartesian Therapeutics, Inc. (RNAC)
7.39
-0.73
(-8.99%)
USD |
NASDAQ |
Mar 13, 16:00
7.41
+0.02
(+0.27%)
After-Hours: 20:00
Cartesian Therapeutics EPS Diluted (Quarterly) : -3.559 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -92.58M |
| Revenue (Quarterly) | 0.947M |
| Total Expenses (Quarterly) | 93.52M |
| Enterprise Value | 79.70M |
| Gross Profit Margin (Quarterly) | 35.80% |
| Profit Margin (Quarterly) | -9.78K% |
| Earnings Yield | -67.97% |
| Normalized Earnings Yield | -46.87 |